ASX - By Stock
|
MSB |
Re:
Pick the Closing Price after FDA approval on that day
|
|
ViperX1
|
449 |
191K |
1 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
449
|
191K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
ViperX1
|
23K |
13M |
1 |
24/01/20 |
24/01/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
ViperX1
|
32 |
17K |
1 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
32
|
17K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Notice Received Under Section 249D of the Corporations Act
|
|
ViperX1
|
23 |
7.7K |
2 |
01/07/19 |
01/07/19 |
ASX - By Stock
|
23
|
7.7K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update
|
|
ViperX1
|
20 |
7.2K |
6 |
13/06/19 |
13/06/19 |
ASX - By Stock
|
20
|
7.2K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Appendix 4C - March 2019 Quarter
|
|
ViperX1
|
8 |
2.8K |
6 |
24/04/19 |
24/04/19 |
ASX - By Stock
|
8
|
2.8K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
ViperX1
|
4.4K |
2.4M |
2 |
25/03/19 |
25/03/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Receipt of R&D tax rebate
|
|
ViperX1
|
8 |
3.2K |
2 |
23/03/19 |
23/03/19 |
ASX - By Stock
|
8
|
3.2K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update
|
|
ViperX1
|
25 |
7.5K |
2 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
25
|
7.5K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - 2019
|
|
ViperX1
|
4.4K |
2.4M |
1 |
20/03/19 |
20/03/19 |
ASX - By Stock
|
4.4K
|
2.4M
|
1
|
|
ASX - By Stock
|
DLM |
Re:
got a letter from the new mob PVD
|
|
ViperX1
|
29 |
18K |
1 |
19/03/19 |
19/03/19 |
ASX - By Stock
|
29
|
18K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Response to ASX Query
|
|
ViperX1
|
61 |
15K |
3 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
61
|
15K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
A Question never answered by this Board
|
|
ViperX1
|
9 |
2.4K |
1 |
01/03/19 |
01/03/19 |
ASX - By Stock
|
9
|
2.4K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
A Question never answered by this Board
|
|
ViperX1
|
9 |
2.4K |
2 |
01/03/19 |
01/03/19 |
ASX - By Stock
|
9
|
2.4K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
A Question never answered by this Board
|
|
ViperX1
|
9 |
2.4K |
5 |
26/02/19 |
26/02/19 |
ASX - By Stock
|
9
|
2.4K
|
5
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update
|
|
ViperX1
|
16 |
6.0K |
1 |
15/02/19 |
15/02/19 |
ASX - By Stock
|
16
|
6.0K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: TOV: Panel Receives Application
|
|
ViperX1
|
38 |
10K |
4 |
08/02/19 |
08/02/19 |
ASX - By Stock
|
38
|
10K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB short selling data - 25th.Jan.2019
|
|
ViperX1
|
100 |
38K |
3 |
03/02/19 |
03/02/19 |
ASX - By Stock
|
100
|
38K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Any guesses? :o)
|
|
ViperX1
|
16 |
6.7K |
5 |
07/01/19 |
07/01/19 |
ASX - By Stock
|
16
|
6.7K
|
5
|
|
ASX - By Stock
|
DLM |
Re:
Letting go
|
|
ViperX1
|
21 |
10K |
7 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
21
|
10K
|
7
|
|
ASX - By Stock
|
DLM |
Re:
What should the Share Price be ?
|
|
ViperX1
|
176 |
36K |
5 |
17/11/18 |
17/11/18 |
ASX - By Stock
|
176
|
36K
|
5
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Results of Phase 2 Clinical Trial
|
|
ViperX1
|
156 |
77K |
6 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
156
|
77K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Massive news coming
|
|
ViperX1
|
32 |
13K |
3 |
04/11/18 |
04/11/18 |
ASX - By Stock
|
32
|
13K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Massive news coming
|
|
ViperX1
|
32 |
13K |
1 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Massive news coming
|
|
ViperX1
|
32 |
13K |
1 |
03/11/18 |
03/11/18 |
ASX - By Stock
|
32
|
13K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Something big coming
|
|
ViperX1
|
35 |
17K |
1 |
02/11/18 |
02/11/18 |
ASX - By Stock
|
35
|
17K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
for what purpose?
|
|
ViperX1
|
30 |
9.6K |
13 |
01/11/18 |
01/11/18 |
ASX - By Stock
|
30
|
9.6K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
ViperX1
|
3.4K |
1.3M |
4 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
4
|
|
ASX - By Stock
|
DLM |
Game On From Next Week
|
|
ViperX1
|
1 |
789 |
15 |
26/10/18 |
26/10/18 |
ASX - By Stock
|
1
|
789
|
15
|
|
ASX - By Stock
|
DLM |
Re:
book
|
|
ViperX1
|
212 |
61K |
1 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
212
|
61K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
ViperX1
|
3.4K |
1.3M |
1 |
16/10/18 |
16/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Factor Therapeutics Appoints Transaction Advisor
|
|
ViperX1
|
41 |
9.8K |
3 |
16/10/18 |
16/10/18 |
ASX - By Stock
|
41
|
9.8K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Some random thoughts on valuation...
|
|
ViperX1
|
7 |
1.7K |
6 |
16/10/18 |
16/10/18 |
ASX - By Stock
|
7
|
1.7K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB trading
|
|
ViperX1
|
3.4K |
1.3M |
0 |
10/10/18 |
10/10/18 |
ASX - By Stock
|
3.4K
|
1.3M
|
0
|
|
ASX - By Stock
|
DLM |
Results could come earlier than mid November?
|
|
ViperX1
|
1 |
840 |
15 |
08/10/18 |
08/10/18 |
ASX - By Stock
|
1
|
840
|
15
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Shareholder Update Q3 2018
|
|
ViperX1
|
57 |
17K |
1 |
05/10/18 |
05/10/18 |
ASX - By Stock
|
57
|
17K
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: Last patient completes treatment in VLU Ph 2 Clinical Trial
|
|
ViperX1
|
20 |
9.5K |
6 |
04/10/18 |
04/10/18 |
ASX - By Stock
|
20
|
9.5K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Thoughts on Annual Report
|
|
ViperX1
|
3 |
589 |
1 |
30/09/18 |
30/09/18 |
ASX - By Stock
|
3
|
589
|
1
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO presentation to Broker Meets Biotech - Perth
|
|
ViperX1
|
86 |
29K |
6 |
19/09/18 |
19/09/18 |
ASX - By Stock
|
86
|
29K
|
6
|
|
ASX - By Stock
|
DLM |
Re:
would be nice to see a little more push from management
|
|
ViperX1
|
33 |
18K |
2 |
13/08/18 |
13/08/18 |
ASX - By Stock
|
33
|
18K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
5x broker valuation of 33c
|
|
ViperX1
|
87 |
32K |
2 |
09/08/18 |
09/08/18 |
ASX - By Stock
|
87
|
32K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Study with Very Similar Control Arm
|
|
ViperX1
|
7 |
4.7K |
16 |
06/08/18 |
06/08/18 |
ASX - By Stock
|
7
|
4.7K
|
16
|
|
ASX - By Stock
|
DLM |
Re:
Study with Very Similar Control Arm
|
|
ViperX1
|
7 |
4.7K |
3 |
05/08/18 |
05/08/18 |
ASX - By Stock
|
7
|
4.7K
|
3
|
|
ASX - By Stock
|
DLM |
Study with Very Similar Control Arm
|
|
ViperX1
|
7 |
4.7K |
26 |
05/08/18 |
05/08/18 |
ASX - By Stock
|
7
|
4.7K
|
26
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO Presentation to Bioshares Conference
|
|
ViperX1
|
61 |
19K |
9 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
61
|
19K
|
9
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO Presentation to Bioshares Conference
|
|
ViperX1
|
61 |
19K |
2 |
01/08/18 |
01/08/18 |
ASX - By Stock
|
61
|
19K
|
2
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO Presentation to Bioshares Conference
|
|
ViperX1
|
61 |
19K |
3 |
30/07/18 |
30/07/18 |
ASX - By Stock
|
61
|
19K
|
3
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO Presentation to Bioshares Conference
|
|
ViperX1
|
61 |
19K |
19 |
28/07/18 |
28/07/18 |
ASX - By Stock
|
61
|
19K
|
19
|
|
ASX - By Stock
|
DLM |
Re:
Ann: CEO Presentation to Bioshares Conference
|
|
ViperX1
|
61 |
19K |
7 |
27/07/18 |
27/07/18 |
ASX - By Stock
|
61
|
19K
|
7
|
|
ASX - By Stock
|
DLM |
Re:
5x broker valuation of 33c
|
|
ViperX1
|
87 |
32K |
2 |
24/07/18 |
24/07/18 |
ASX - By Stock
|
87
|
32K
|
2
|
|